Heart Failure Resilience Intervention for Caregivers
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT03963583
- Status
- Completed
Conditions
- Caregivers
- Heart Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- HEROIC — BEHAVIORALThe HEROIC intervention will include individualized, nurse-led sessions focused on; 1. a whole-person assessment including preventive health behaviors, personal goals, and purpose in life 2. discussion of caregiving in the context of the caregiver's identified 'purpose' which supports meaning-making and provides rationale for goal-setting 3. co-development of a plan to address caregiver goals to improve preventive health behaviors and/or reduce caregiver burden 4. 'walking meetings' to model the importance of exercise while discussing incremental action plans to help caregivers achieve goals.
Study Details
Heart failure (HF) patients with supportive caregivers have better physical health, emotional health, and quality of life. But caregivers have an increased risk of caregivers' own worsening health and often feel a sense of burden related to caregiving. However, caregivers receive very little support to balance caring for the patient with caring for themselves. Therefore, this research will provide a program for caregivers of advanced heart failure patients to build on the caregiver's strengths, sense of purpose, and set goals for healthy lifestyle changes. The investigators believe that caregivers who receive the program will have better quality of life, less sense of burden, and a healthier lifestyle.
Key Dates
- Start date
- Apr 1, 2022
- Status verified
- Nov 2025
- Primary completion
- Oct 31, 2024
- Completion
- Oct 31, 2024
Study Design
- Enrollment
- 33 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: HEROIC Intervention GroupThis group will receive the HEROIC intervention.
- Experimental: Waitlist Control GroupThe waitlisted group will receive usual care for caregivers for the first 12 weeks, which is normally limited to inclusion in some clinical assessment and teaching during patient visits. Waitlisted participants will receive monthly study postcards to encourage retention. After 12 weeks, they will begin the intervention.
Primary Outcome Measure
Goal Attainment of Preventive Health Behaviors as Measured by the Goal Attainment Scale [ Time Frame: Baseline, 12 and 24 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins School of Nursing | Baltimore | Maryland | 21205 | - |
Find similar trials in Baltimore, MD
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationPHASE3 · Recruiting · Novo Nordisk A/S · Alexander City, Alabama